U.S. patent application number 09/848841 was filed with the patent office on 2003-09-11 for disease resistance factors.
Invention is credited to Butler, Karlene H., Falco, Saverio Carl, Famodu, Omolayo O., Fang, Yiwen, Han, Feng, Heppard, Elmer P., Liu, Zhan-Bin, Miao, Guo-Hua, Odell, Joan T., Rafalski, J. Antoni.
Application Number | 20030172411 09/848841 |
Document ID | / |
Family ID | 22315623 |
Filed Date | 2003-09-11 |
United States Patent
Application |
20030172411 |
Kind Code |
A1 |
Butler, Karlene H. ; et
al. |
September 11, 2003 |
Disease resistance factors
Abstract
This invention relates to isolated nucleic acid fragments
encoding corn (Zea mays), rice (Oryza sativa), or wheat (Triticum
aestivum) NPR1 homologs. The invention also relates to the
construction of a chimeric gene encoding all or a portion of the
NPR1 homolog, in sense or antisense orientation, wherein expression
of the chimeric gene results in production of altered levels of the
NPR1 homolog in a transformed host cell.
Inventors: |
Butler, Karlene H.; (Newark,
DE) ; Falco, Saverio Carl; (Arden, DE) ;
Famodu, Omolayo O.; (Newark, DE) ; Fang, Yiwen;
(Los Angeles, CA) ; Han, Feng; (Johnston, IA)
; Heppard, Elmer P.; (Wilmington, DE) ; Liu,
Zhan-Bin; (Greenville, DE) ; Odell, Joan T.;
(Unionville, PA) ; Rafalski, J. Antoni;
(Wilmington, DE) ; Miao, Guo-Hua; (Johnston,
IA) |
Correspondence
Address: |
E I DU PONT DE NEMOURS AND COMPANY
LEGAL PATENT RECORDS CENTER
BARLEY MILL PLAZA 25/1128
4417 LANCASTER PIKE
WILMINGTON
DE
19805
US
|
Family ID: |
22315623 |
Appl. No.: |
09/848841 |
Filed: |
May 4, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
09848841 |
May 4, 2001 |
|
|
|
PCT/US99/25953 |
Oct 4, 1999 |
|
|
|
60107242 |
Nov 5, 1998 |
|
|
|
Current U.S.
Class: |
800/298 ;
435/419; 435/468; 530/350; 536/23.6; 800/279 |
Current CPC
Class: |
C12N 15/8279 20130101;
C12N 9/0004 20130101; C12N 15/8209 20130101; C07K 14/415
20130101 |
Class at
Publication: |
800/298 ;
536/23.6; 435/419; 435/468; 800/279; 530/350 |
International
Class: |
A01H 005/00; C12N
015/82 |
Claims
What is claimed is:
1. An isolated polynucleotide that encodes an NPR1 polypeptide
having a sequence identity of at least 80% based on the Clustal
method of alignment when compared to a polypeptide selected from
the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and
16.
2. The polynucleotide of claim 1 wherein the sequence identity is
at least 85%.
3. The polynucleotide of claim 1 wherein the sequence identity is
at least 90%.
4. The polynucleotide of claim 1 wherein the sequence identity is
at least 95%.
5. The polynucleotide of claim 1 wherein the polynucleotide encodes
a polypeptide selected from the group consisting of SEQ ID NOs: 2,
4, 6, 8, 10, 12, 14, and 16.
6. The polynucleotide of claim 1 wherein the polynucleotide
comprises a nucleotide sequence selected from the group consisting
of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, and 15.
7. The polynucleotide of claim 1 wherein the polypeptide is an
NPR1.
8. An isolated complement of the polynucleotide of claim 1, wherein
(a) the complement and the polynucleotide consist of the same
number of nucleotides, and (b) the nucleotide sequences of the
complement and the polynucleotide have 100% complementarity.
9. An isolated nucleic acid molecule that (1) comprises at least
100 nucleotides and (2) remains hybridized with the isolated
polynucleotide of claim 1 under a wash condition of 0.1.times.SSC,
0.1% SDS, and 65.degree. C.
10. A cell comprising the polynucleotide of claim 1.
11. The cell of claim 10, wherein the cell is selected from the
group consisting of a yeast cell, a bacterial cell and a plant
cell.
12. A virus comprising the polynucleotide of claim 1.
13. A transgenic plant comprising the polynucleotide of claim
1.
14. A method for transforming a cell, comprising introducing into a
cell the polynucleotide of claim 1.
15. A method for producing a transgenic plant comprising (a)
transforming a plant cell with the polynucleotide of claim 1, and
(b) regenerating a plant from the transformed plant cell.
16. A method for producing a polynucleotide fragment comprising (a)
selecting a nucleotide sequence comprised by the polynucleotide of
claim 1, and (b) synthesizing a polynucleotide fragment containing
the nucleotide sequence.
17. The method of claim 16, wherein the fragment is produced in
vivo.
18. An isolated NPR1 polypeptide that has a sequence identity of at
least 80% based on the Clustal method compared to an amino acid
sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6,
8, 10, 12, 14, and 16.
19. The isolated polypeptide of claim 18 wherein the sequence
identity is at least 85%.
20. The isolated polypeptide of claim 18 wherein the sequence
identity is at least 90%.
21. The isolated polypeptide of claim 18 wherein the sequence
identity is at least 95%.
22. The polypeptide of claim 18 wherein the polypeptide has a
sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6,
8, 10, 12, 14, and 16.
23. The polypeptide of claim 18, wherein the polypeptide is aNPR1
.
24. A chimeric gene comprising the polynucleotide of claim 1
operably linked to at least one regulatory sequence.
25. A method for altering the level of pathogen resistance in a
plant, the method comprising the steps of: (a) transforming a plant
cell with a chimeric gene containing the polypeptide of claim 1;
(b) culturing the transformed plant cell under conditions suitable
for the expression of the chimeric gene; (c) maintaining the plant
cell under conditions that are suitable for its development into a
plant; and (d) comparing the level of pathogen resistance of the
plant cell containing the polynucleotide of claim 1 and a plant
cell not containing the polynucleotide of claim 1.
Description
[0001] This application claims the benefit of International
Application No. PCT/US99/25953, filed Nov. 4, 1999, which claims
priority of U.S. Provisional Application No. 60/107,242, filed Nov.
5, 1998.
FIELD OF THE INVENTION
[0002] This invention is in the field of plant molecular biology.
More specifically, this invention pertains to nucleic acid
fragments encoding corn (Zea mays), rice (Oryza sativa) and wheat
(Triticum aestivum) NPR1 polypeptides in plants and seeds.
BACKGROUND OF THE INVENTION
[0003] Pathogens annually cause billions of dollars in damage to
crops worldwide. Consequently, an increasing amount of research has
been dedicated to developing novel methods for controlling plant
diseases. Such studies have centered on the plant's innate ability
to resist pathogen invasion in an effort to support the plant's own
defenses to counter pathogen attacks. One such defense mechanism
under study is known as systemic acquired resistance (SAR; reviewed
in Ryals et al. (1996) Plant Cell 8:1809-1819). SAR is defined as a
generalized defense response, which is often induced by avirulent
pathogens and provides enhanced resistance to a broad spectrum of
virulent pathogens. Avirulent pathogens carry an avirulence (avr)
gene whose product can be recognized by the product of a
corresponding resistance (R) gene carried by plants. Such
recognition triggers both a programmed cell death response, known
as the hypersensitive response (HR), around the point of pathogen
infection and release of a systemic SAR-inducing signal. After a
rapid and localized HR, the elevated state of resistance associated
with SAR is effective throughout the plant for a period of time
ranging from several days to a few weeks. Coinciding with the onset
of SAR is the transcriptional activation of the
pathogenesis-related (PR) genes. These genes encode proteins that
exhibit antimicrobial activities (Ward et al. (1991) Plant Cell
3:1085-1094).
[0004] In Arabidopsis, expression of PR-1, .beta.-1,3-glucanase
(BGL2), and PR-5 has been shown to be tightly correlated with
resistance to virulent bacterial, fungal, and oomycete pathogens;
therefore, these genes are used as molecular markers for SAR (Uknes
et al. (1992) Plant Cell 4:645-656). The Arabidopsis NPR1 controls
the onset of SAR. Mutants with defects in NPR1 fail to respond to
various SAR-inducing treatments, displaying little expression of PR
genes and exhibiting increased susceptibility to infections. NPR1
was cloned using a map-based approach and was found to encode a
novel protein containing ankyrin repeats. The lesion in one npr1
mutant allele disrupted the ankyrin consensus sequence, suggesting
that these repeats are important for NPR1 function. Transformation
of the cloned wild-type NPR1 gene into npr1 mutants complemented
the mutations restoring the responsiveness to SAR induction with
respect to PR-gene expression and resistance to infections. This
transformation also rendered the transgenic plants more resistant
to infection by P. syringae in the absence of SAR induction (Cao et
al. (1997) Cell 88:57-63).
[0005] Identification of cDNAs encoding NPR1 in other crops will
permit its manipulation and thus the control of crop pathogens.
SUMMARY OF THE INVENTION
[0006] The present invention concerns isolated polynucleotides
comprising a nucleotide sequence encoding at least a portion of an
NPR1 polypeptide.
[0007] The present invention concerns isolated polynucleotides
comprising a nucleotide sequence selected from the group consisting
of: (a) a nucleotide sequence encoding an NPR1 polypeptide having
at least 80% identity, based on the Clustal method of alignment,
when compared to a polypeptide selected from the group consisting
of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16. It is preferred that
the identity be at least 85%, it is preferable if the identity is
at least 90%, it is more preferred that the identity be at least
95%. This invention also relates to the isolated complement of such
polynucleotides, wherein the complement and the polynucleotide
consist of the same number of nucleotides, and the nucleotide
sequences of the complement and the polynucleotide have 100%
complementarity.
[0008] In a third embodiment nucleotide sequence of the isolated
first polynucleotide is selected from SEQ ID NOs: 1, 3, 5, 7, 9,
11, 13, 15, and 17.
[0009] In a fourth embodiment, this invention concerns an isolated
polynucleotide encoding an NPR1 polypeptide.
[0010] In a fifth embodiment, this invention relates to a chimeric
gene comprising the polynucleotide of the present invention.
[0011] In a sixth embodiment, the present invention concerns an
isolated nucleic acid molecule that comprises at least 100
nucleotides and remains hybridized with the isolated polynucleotide
of the present invention under a wash condition of 0.1.times.SSC,
0.1% SDS, and 65.degree. C.
[0012] In a seventh embodiment, the invention also relates to a
host cell comprising a chimeric gene of the present invention or an
isolated polynucleotide of the present invention. The host cell may
be eukaryotic, such as a yeast cell or a plant cell, or
prokaryotic, such as a bacterial cell. The present invention may
also relate to a virus comprising an isolated polynucleotide of the
present invention or a chimeric gene of the present invention.
[0013] In an eighth embodiment, the invention concerns a transgenic
plant comprising a polynucleotide of the present invention.
[0014] In a ninth embodiment, the invention relates to a method for
transforming a cell by introducing into such cell the
polynucleotide of the present invention, or a method of producing a
transgenic plant by transforming a plant cell with the
polynucleotide of the present invention and regenerating a plant
from the transformed plant cell.
[0015] In a tenth embodiment, the invention concerns a method for
producing a nucleotide fragment by selecting a nucleotide sequence
comprised by a polynucleotide of the present invention and
synthesizing a polynucleotide fragment containing the nucleotide
sequence. It is understood that the nucleotide fragment may be
produced in vitro or in vivo.
[0016] In an eleventh embodiment the invention concerns an isolated
polypeptide comprising an amino acid sequence selected from the
group consisting of: (a) an NPR1 polypeptide having a sequence
identity of at least 80%, based on the Clustal method of alignment,
when compared to an amino acid sequence selected from the group
consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16. It is
preferred that the identity be at least 85%, it is more preferred
if the identity is at least 90%, it is preferable that the identity
be at least 95%.
[0017] In a twelfth embodiment the invention relates to an isolated
polypleptide selected from SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and
16.
[0018] In a thirteenth embodiment, this invention concerns an
isolated polypeptide having NPR1 function.
[0019] In a fourteenth embodiment, this invention relates to a
method of altering the level of expression of an NPR1 in a host
cell comprising: transforming a host cell with a chimeric gene of
the present invention; and growing the transformed host cell under
conditions that are suitable for expression of the chimeric
gene.
BRIEF DESCRIPTION OF THE DRAWING AND SEQUENCE LISTINGS
[0020] The invention can be more fully understood from the
following detailed description and the accompanying drawing and
Sequence Listing which form a part of this application.
[0021] FIG. 1 shows a comparison of the amino acid sequences
derived from corn clone cdt1c.pk001.16 (EST, SEQ ID NO: 2), corn
clone p0006.cbyvc82rx (FIS, SEQ ID NO: 8), rice clone
rr1.pk0001.a11 (EST, SEQ ID NO: 4; FIS, SEQ ID NO: 12; and CGS, SEQ
ID NO: 16), rice clone r10n.pk0063.d10 (FIS, SEQ ID NO: 10), and
wheat clone wre1n.pk0122.c2 (EST, SEQ ID NO: 6; and FIS, SEQ ID NO:
14) with the NPR1 from Arabidopsis thaliana (NCBI General
Identifier No. 1773295; SEQ ID NO: 17). Amino acids conserved among
all sequences are indicated by an asterisk (*) below the alignment.
Dashes are used by the program to maximize the alignment. Numbers
above the alignment refer to the relative amino acid position. FIG.
1A shows amino acids 1 through 120, FIG. 1B shows amino acids 121
through 240, FIG. 1C shows amino acids 241 through 360, FIG. 1D
shows amino acids 361 through 480, FIG. 1E shows amino acids 481
through 600, FIG. 1F shows amino acids 601 through 659.
[0022] Table 1 lists the plant source of the polypeptides that are
described herein, the designation of the cDNA clones that comprise
the nucleic acid fragments encoding polypeptides representing all
or a substantial portion of these polypeptides. Table 1 also lists
the source of the polypeptides to which the polypeptides of the
present invention show homology to and the NCBI General Identifier
Nos. of such polypeptides. Finally, Table 1 lists the corresponding
identifier (SEQ ID NO:) as used in the attached Sequence Listing.
The sequence descriptions and Sequence Listing attached hereto
comply with the rules governing nucleotide and/or amino acid
sequence disclosures in patent applications as set forth in 37
C.F.R. .sctn.1.821-1.825.
1TABLE 1 NPR1 Homologs SEQ ID NO: Plant Clone Designation
(Nucleotide) (Amino Acid) Corn cdt1c.pk001.16 1 2 Rice
rr1.pk0001.a11 3 4 Wheat wre1n.pk0122.c2 5 6 Corn p0006.cbyvc82rx 7
8 Rice r10n.pk0063.d10:fis 9 10 Rice rr1.pk0001.a11:fis 11 12 Wheat
wre1n.pk0122.c2:fis 13 14 Rice rr1.pk0001.a11:cgs 15 16 Arabidopsis
NCBI gi 1773295 17 thaliana
[0023] The Sequence Listing contains the one letter code for
nucleotide sequence characters and the three letter codes for amino
acids as defined in conformity with the IUPAC-IUBMB standards
described in Nucleic Acids Res. 13:3021-3030 (1985) and in the
Biochemical J. 219 (No. 2):345-373 (1984) which are herein
incorporated by reference. The symbols and format used for
nucleotide and amino acid sequence data comply with the rules set
forth in 37 C.F.R. .sctn.1.822.
DETAILED DESCRIPTION OF THE INVENTION
[0024] In the context of this disclosure, a number of terms shall
be utilized. The terms "polynucleotide", "polynucleotide sequence",
"nucleic acid sequence", and "nucleic acid fragment"/"isolated
nucleic acid fragment" are used interchangeably herein. These terms
encompass nucleotide sequences and the like. A polynucleotide may
be a polymer of RNA or DNA that is single- or double-stranded, that
optionally contains synthetic, non-natural or altered nucleotide
bases. A polynucleotide in the form of a polymer of DNA may be
comprised of one or more segments of cDNA, genomic DNA, synthetic
DNA, or mixtures thereof. An isolated polynucleotide of the present
invention may include at least 60 contiguous nucleotides,
preferably at least 40 contiguous nucleotides, most preferably at
least 30 contiguous nucleotides derived from SEQ ID NOs: 1, 3, 5,
7, 9, 11, 13, and 15, or the complement of such sequences.
[0025] The term "isolated" polynucleotide refers to a
polynucleotide that is substantially free from other nucleic acid
sequences, such as and not limited to other chromosomal and
extrachromosomal DNA and RNA. Isolated polynucleotides may be
purified from a host cell in which they naturally occur.
Conventional nucleic acid purification methods known to skilled
artisans may be used to obtain isolated polynucleotides. The term
also embraces recombinant polynucleotides and chemically
synthesized polynucleotides.
[0026] The term "recombinant" means, for example, that a nucleic
acid sequence is made by an artificial combination of two otherwise
separated segments of sequence, e.g., by chemical synthesis or by
the manipulation of isolated nucleic acids by genetic engineering
techniques.
[0027] As used herein, "substantially similar" refers to nucleic
acid fragments wherein changes in one or more nucleotide bases
results in substitution of one or more amino acids, but do not
affect the functional properties of the polypeptide encoded by the
nucleotide sequence. "Substantially similar" also refers to nucleic
acid fragments wherein changes in one or more nucleotide bases does
not affect the ability of the nucleic acid fragment to mediate
alteration of gene expression by gene silencing through for example
antisense or co-suppression technology. "Substantially similar"
also refers to modifications of the nucleic acid fragments of the
instant invention such as deletion or insertion of one or more
nucleotides that do not substantially affect the functional
properties of the resulting transcript vis-a-vis the ability to
mediate gene silencing or alteration of the functional properties
of the resulting protein molecule. It is therefore understood that
the invention encompasses more than the specific exemplary
nucleotide or amino acid sequences and includes functional
equivalents thereof. The terms "substantially similar" and
"corresponding substantially" are used interchangeably herein.
[0028] Substantially similar nucleic acid fragments may be selected
by screening nucleic acid fragments representing subfragments or
modifications of the nucleic acid fragments of the instant
invention, wherein one or more nucleotides are substituted, deleted
and/or inserted, for their ability to affect the level of the
polypeptide encoded by the unmodified nucleic acid fragment in a
plant or plant cell. For example, a substantially similar nucleic
acid fragment representing at least 30 contiguous nucleotides
derived from the instant nucleic acid fragment can be constructed
and introduced into a plant or plant cell. The level of the
polypeptide encoded by the unmodified nucleic acid fragment present
in a plant or plant cell exposed to the substantially similar
nucleic fragment can then be compared to the level of the
polypeptide in a plant or plant cell that is not exposed to the
substantially similar nucleic acid fragment.
[0029] For example, it is well known in the art that antisense
suppression and co-suppression of gene expression may be
accomplished using nucleic acid fragments representing less than
the entire coding region of a gene, and by using nucleic acid
fragments that do not share 100% sequence identity with the gene to
be suppressed. Moreover, alterations in a nucleic acid fragment
which result in the production of a chemically equivalent amino
acid at a given site, but do not effect the functional properties
of the encoded polypeptide, are well known in the art. Thus, a
codon for the amino acid alanine, a hydrophobic amino acid, may be
substituted by a codon encoding another less hydrophobic residue,
such as glycine, or a more hydrophobic residue, such as valine,
leucine, or isoleucine. Similarly, changes which result in
substitution of one negatively charged residue for another, such as
aspartic acid for glutamic acid, or one positively charged residue
for another, such as lysine for arginine, can also be expected to
produce a functionally equivalent product. Nucleotide changes which
result in alteration of the N-terminal and C-terminal portions of
the polypeptide molecule would also not be expected to alter the
activity of the polypeptide. Each of the proposed modifications is
well within the routine skill in the art, as is determination of
retention of biological activity of the encoded products.
[0030] Consequently, an isolated polynucleotide comprising a
nucleotide sequence of at least 60 (preferably at least 40, most
preferably at least 30) contiguous nucleotides derived from a
nucleotide sequence selected from the group consisting of SEQ ID
NOs: 1, 3, 5, 7, 9, 11, 13, and 25, and the complement of such
nucleotide sequences may be used in methods of selecting an
isolated polynucleotide that affects the expression of an NPR1
polypeptide in a host cell. A method of selecting an isolated
polynucleotide that affects the level of expression of a
polypeptide in a virus or in a host cell (eukaryotic, such as plant
or yeast, prokaryotic such as bacterial) may comprise the steps of:
constructing an isolated polynucleotide of the present invention or
an isolated chimeric gene of the present invention; introducing the
isolated polynucleotide or the isolated chimeric gene into a host
cell; measuring the level of a polypeptide or enzyme activity in
the host cell containing the isolated polynucleotide; and comparing
the level of a polypeptide or enzyme activity in the host cell
containing the isolated polynucleotide with the level of a
polypeptide or enzyme activity in a host cell that does not contain
the isolated polynucleotide.
[0031] Moreover, substantially similar nucleic acid fragments may
also be characterized by their ability to hybridize. Estimates of
such homology are provided by either DNA-DNA or DNA-RNA
hybridization under conditions of stringency as is well understood
by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic
Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions
can be adjusted to screen for moderately similar fragments, such as
homologous sequences from distantly related organisms, to highly
similar fragments, such as genes that duplicate functional enzymes
from closely related organisms. Post-hybridization washes determine
stringency conditions. One set of preferred conditions uses a
series of washes starting with 6.times.SSC, 0.5% SDS at room
temperature for 15 min, then repeated with 2.times.SSC, 0.5% SDS at
45.degree. C. for 30 min, and then repeated twice with
0.2.times.SSC, 0.5% SDS at 50.degree. C. for 30 min. A more
preferred set of stringent conditions uses higher temperatures in
which the washes are identical to those above except for the
temperature of the final two 30 min washes in 0.2.times.SSC, 0.5%
SDS was increased to 60.degree. C. Another preferred set of highly
stringent conditions uses two final washes in 0.1.times.SSC, 0.1%
SDS at 65.degree. C.
[0032] Substantially similar nucleic acid fragments of the instant
invention may also be characterized by the percent identity of the
amino acid sequences that they encode to the amino acid sequences
disclosed herein as determined by algorithms commonly employed by
those skilled in this art. Suitable nucleic acid fragments
(isolated polynucleotides of the present invention) encode
polypeptides that are at least about 70% identical, preferably at
least about 80% identical to the amino acid sequences reported
herein. Preferred nucleic acid fragments encode amino acid
sequences that are at least about 85% identical to the amino acid
sequences reported herein. More preferred nucleic acid fragments
encode amino acid sequences that are at least about 90% identical
to the amino acid sequences reported herein. Most preferred are
nucleic acid fragments that encode amino acid sequences that are at
least about 95% identical to the amino acid sequences reported
herein. Suitable nucleic acid fragments not only have the above
identities but typically encode a polypeptide having at least 50
amino acids, preferably at least 100 amino acids, more preferably
at least 150 amino acids, still more preferably at least 200 amino
acids, and most preferably at least 250 amino acids. Sequence
alignments and percent identity calculations were performed using
the Megalign program of the LASERGENE bioinformatics computing
suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the
sequences was performed using the Clustal method of alignment
(Higgins and Sharp (1989) CABIOS. 5:151-153) with the default
parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default
parameters for pairwise alignments using the Clustal method were
KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5.
[0033] A "substantial portion" of an amino acid or nucleotide
sequence comprises an amino acid or a nucleotide sequence that is
sufficient to afford putative identification of the protein or gene
that the amino acid or nucleotide sequence comprises. Amino acid
and nucleotide sequences can be evaluated either manually by one
skilled in the art, or by using computer-based sequence comparison
and identification tools that employ algorithms such as BLAST
(Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol.
Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST- /). In
general, to putatively identify a polypeptide or nucleic acid
sequence as homologous to a known protein or gene a sequence of ten
or more contiguous amino acids or thirty or more contiguous
nucleotides is necessary. Moreover, with respect to nucleotide
sequences, gene-specific oligonucleotide probes comprising 30 or
more contiguous nucleotides may be used in sequence-dependent
methods of gene identification (e.g., Southern hybridization) and
isolation (e.g., in situ hybridization of bacterial colonies or
bacteriophage plaques). In addition, short oligonucleotides of 12
or more contiguous nucleotides may be used as amplification primers
in PCR in order to obtain a particular nucleic acid fragment
comprising the primers. Accordingly, a "substantial portion" of a
nucleotide sequence comprises a nucleotide sequence that will
afford specific identification and/or isolation of a nucleic acid
fragment comprising the sequence. The instant specification teaches
amino acid and nucleotide sequences encoding polypeptides that
comprise one or more particular plant proteins. The skilled
artisan, having the benefit of the sequences as reported herein,
may now use all or a substantial portion of the disclosed sequences
for purposes known to those skilled in this art. Accordingly, the
instant invention comprises the complete sequences as reported in
the accompanying Sequence Listing, as well as substantial portions
of those sequences as defined above.
[0034] "Codon degeneracy" refers to divergence in the genetic code
permitting variation of the nucleotide sequence without effecting
the amino acid sequence of an encoded polypeptide. Accordingly, the
instant invention relates to any nucleic acid fragment comprising a
nucleotide sequence that encodes all or a substantial portion of
the amino acid sequences set forth herein. The skilled artisan is
well aware of the "codon-bias" exhibited by a specific host cell in
usage of nucleotide codons to specify a given amino acid.
Therefore, when synthesizing a nucleic acid fragment for improved
expression in a host cell, it is desirable to design the nucleic
acid fragment such that its frequency of codon usage approaches the
frequency of preferred codon usage of the host cell.
[0035] "Synthetic nucleic acid fragments" can be assembled from
oligonucleotide building blocks that are chemically synthesized
using procedures known to those skilled in the art. These building
blocks are ligated and annealed to form larger nucleic acid
fragments which may then be enzymatically assembled to construct
the entire desired nucleic acid fragment. "Chemically synthesized",
as related to a nucleic acid fragment, means that the component
nucleotides were assembled in vitro. Manual chemical synthesis of
nucleic acid fragments may be accomplished using well established
procedures, or automated chemical synthesis can be performed using
one of a number of commercially available machines. Accordingly,
the nucleic acid fragments can be tailored for optimal gene
expression based on optimization of the nucleotide sequence to
reflect the codon bias of the host cell. The skilled artisan
appreciates the likelihood of successful gene expression if codon
usage is biased towards those codons favored by the host.
Determination of preferred codons can be based on a survey of genes
derived from the host cell where sequence information is
available.
[0036] "Gene" refers to a nucleic acid fragment that expresses a
specific protein, including regulatory sequences preceding (5'
non-coding sequences) and following (3' non-coding sequences) the
coding sequence. "Native gene" refers to a gene as found in nature
with its own regulatory sequences. "Chimeric gene" refers any gene
that is not a native gene, comprising regulatory and coding
sequences that are not found together in nature. Accordingly, a
chimeric gene may comprise regulatory sequences and coding
sequences that are derived from different sources, or regulatory
sequences and coding sequences derived from the same source, but
arranged in a manner different than that found in nature.
"Endogenous gene" refers to a native gene in its natural location
in the genome of an organism. A "foreign-gene" refers to a gene not
normally found in the host organism, but that is introduced into
the host organism by gene transfer. Foreign genes can comprise
native genes inserted into a non-native organism, or chimeric
genes. A "transgene" is a gene that has been introduced into the
genome by a transformation procedure.
[0037] "Coding sequence" refers to a nucleotide sequence that codes
for a specific amino acid sequence. "Regulatory sequences" refer to
nucleotide sequences located upstream (5' non-coding sequences),
within, or downstream (3' non-coding sequences) of a coding
sequence, and which influence the transcription, RNA processing or
stability, or translation of the associated coding sequence.
Regulatory sequences may include promoters, translation leader
sequences, introns, and polyadenylation recognition sequences.
[0038] "Promoter" refers to a nucleotide sequence capable of
controlling the expression of a coding sequence or functional RNA.
In general, a coding sequence is located 3' to a promoter sequence.
The promoter sequence consists of proximal and more distal upstream
elements, the latter elements often referred to as enhancers.
Accordingly, an "enhancer" is a nucleotide sequence which can
stimulate promoter activity and may be an innate element of the
promoter or a heterologous element inserted to enhance the level or
tissue-specificity of a promoter. Promoters may be derived in their
entirety from a native gene, or may be composed of different
elements derived from different promoters found in nature, or may
even comprise synthetic nucleotide segments. It is understood by
those skilled in the art that different promoters may direct the
expression of a gene in different tissues or cell types, or at
different stages of development, or in response to different
environmental conditions. Promoters which cause a nucleic acid
fragment to be expressed in most cell types at most times are
commonly referred to as "constitutive promoters". New promoters of
various types useful in plant cells are constantly being
discovered; numerous examples may be found in the compilation by
Okamuro and Goldberg (1989) Biochemistry of Plants 15:1-82. It is
further recognized that since in most cases the exact boundaries of
regulatory sequences have not been completely defined, nucleic acid
fragments of different lengths may have identical promoter
activity.
[0039] "Translation leader sequence" refers to a nucleotide
sequence located between the promoter sequence of a gene and the
coding sequence. The translation leader sequence is present in the
fully processed mRNA upstream of the translation start sequence.
The translation leader sequence may affect processing of the
primary transcript to mRNA, mRNA stability or translation
efficiency. Examples of translation leader sequences have been
described (Turner and Foster (1995) Mol. Biotechnol.
3:225-236).
[0040] "3' non-coding sequences" refer to nucleotide sequences
located downstream of a coding sequence and include polyadenylation
recognition sequences and other sequences encoding regulatory
signals capable of affecting mRNA processing or gene expression.
The polyadenylation signal is usually characterized by affecting
the addition of polyadenylic acid tracts to the 3' end of the mRNA
precursor. The use of different 3' non-coding sequences is
exemplified by Ingelbrecht et al. (1989) Plant Cell 1:671-680.
[0041] "RNA transcript" refers to the product resulting from RNA
polymerase-catalyzed transcription of a DNA sequence. When the RNA
transcript is a perfect complementary copy of the DNA sequence, it
is referred to as the primary transcript or it may be a RNA
sequence derived from posttranscriptional processing of the primary
transcript and is referred to as the mature RNA. "Messenger RNA
(mRNA)" refers to the RNA that is without introns and that can be
translated into polypeptides by the cell. "cDNA" refers to DNA that
is complementary to and derived from an mRNA template. The cDNA can
be single-stranded or converted to double stranded form using, for
example, the Klenow fragment of DNA polymerase I. "Sense-RNA"
refers to an RNA transcript that includes the mRNA and so can be
translated into a polypeptide by the cell. "Antisense RNA" refers
to an RNA transcript that is complementary to all or part of a
target primary transcript or mRNA and that blocks the expression of
a target gene (see U.S. Pat. No. 5,107,065, incorporated herein by
reference). The complementarity of an antisense RNA may be with any
part of the specific nucleotide sequence, i.e., at the 5'
non-coding sequence, 3' non-coding sequence, introns, or the coding
sequence. "Functional RNA" refers to sense RNA, antisense RNA,
ribozyme RNA, or other RNA that may not be translated but yet has
an effect on cellular processes.
[0042] The term "operably linked" refers to the association of two
or more nucleic acid fragments on a single polynucleotide so that
the function of one is affected by the other. For example, a
promoter is operably linked with a coding sequence when it is
capable of affecting the expression of that coding sequence (i.e.,
that the coding sequence is under the transcriptional control of
the promoter). Coding sequences can be operably linked to
regulatory sequences in sense or antisense orientation.
[0043] The term "expression", as used herein, refers to the
transcription and stable accumulation of sense (mRNA) or antisense
RNA derived from the nucleic acid fragment of the invention.
Expression may also refer to translation of mRNA into a
polypeptide. "Antisense inhibition" refers to the production of
antisense RNA transcripts capable of suppressing the expression of
the target protein. "Overexpression" refers to the production of a
gene product in transgenic organisms that exceeds levels of
production in normal or non-transformed organisms. "Co-suppression"
refers to the production of sense RNA transcripts capable of
suppressing the expression of identical or substantially similar
foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated
herein by reference).
[0044] A "protein" or "polypeptide" is a chain of amino acids
arranged in a specific order determined by the coding sequence in a
polynucleotide encoding the polypeptide. Each protein or
polypeptide has a unique function.
[0045] "Altered levels" or "altered expression" refers to the
production of gene product(s) in transgenic organisms in amounts or
proportions that differ from that of normal or non-transformed
organisms.
[0046] "Mature protein" or the term "mature" when used in
describing a protein refers to a post-translationally processed
polypeptide; i.e., one from which any pre- or propeptides present
in the primary translation product have been removed. "Precursor
protein" or the term "precursor" when used in describing a protein
refers to the primary product of translation of mRNA; i.e., with
pre- and propeptides still present. Pre- and propeptides may be but
are not limited to intracellular localization signals.
[0047] A "chloroplast transit peptide" is an amino acid sequence
which is translated in conjunction with a protein and directs the
protein to the chloroplast or other plastid types present in the
cell in which the protein is made. "Chloroplast transit sequence"
refers to a nucleotide sequence that encodes a chloroplast transit
peptide. A "signal peptide" is an amino acid sequence which is
translated in conjunction with a protein and directs the protein to
the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant
Mol. Biol. 42:21-53). If the protein is to be directed to a
vacuole, a vacuolar targeting signal (supra) can further be added,
or if to the endoplasmic reticulum, an endoplasmic reticulum
retention signal (supra) may be added. If the protein is to be
directed to the nucleus, any signal peptide present should be
removed and instead a nuclear localization signal included (Raikhel
(1992) Plant Phys. 100:1627-1632).
[0048] "Transformation" refers to the transfer of a nucleic acid
fragment into the genome of a host organism, resulting in
genetically stable inheritance. Host organisms containing the
transformed nucleic acid fragments are referred to as "transgenic"
organisms. Examples of methods of plant transformation include
Agrobacterium-mediated transformation (De Blaere et al. (1987)
Meth. Enzymol. 143:277) and particle-accelerated or "gene gun"
transformation technology (Klein et al. (1987) Nature (London)
327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by
reference). Thus, isolated polynucleotides of the present invention
can be incorporated into recombinant constructs, typically DNA
constructs, capable of introduction into and replication in a host
cell. Such a construct can be a vector that includes a replication
system and sequences that are capable of transcription and
translation of a polypeptide-encoding sequence in a given host
cell. A number of vectors suitable for stable transfection of plant
cells or for the establishment of transgenic plants have been
described in, e.g., Pouwels et al., Cloning Vectors: A Laboratory
Manual, 1985, supp. 1987; Weissbach and Weissbach, Methods for
Plant Molecular Biology, Academic Press, 1989; and Flevin et al.,
Plant Molecular Biology Manual, Kluwer Academic Publishers, 1990.
Typically, plant expression vectors include, for example, one or
more cloned plant genes under the transcriptional control of 5' and
3' regulatory sequences and a dominant selectable marker. Such
plant expression vectors also can contain a promoter regulatory
region (e.g., a regulatory region controlling inducible or
constitutive, environmentally- or developmentally-regulated, or
cell- or tissue-specific expression), a transcription initiation
start site, a ribosome binding site, an RNA processing signal, a
transcription termination site, and/or a polyadenylation
signal.
[0049] Standard recombinant DNA and molecular cloning techniques
used herein are well known in the art and are described more fully
in Sambrook et al. Molecular Cloning: A Laboratory Manual; Cold
Spring Harbor Laboratory Press: Cold Spring Harbor, 1989
(hereinafter "Maniatis").
[0050] "PCR" or "polymerase chain reaction" is well known by those
skilled in the art as a technique used for the amplification of
specific DNA segments (U.S. Pat. Nos. 4,683,195 and 4,800,159).
[0051] The present invention concerns polynucleotides comprising
nucleotide sequences selected from the group consisting of: (a)
first nucleotide sequence encoding an NPR1 polypeptide having at
least 80% identity based on the Clustal method of alignment when
compared to a polypeptide selected from the group consisting of SEQ
ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16, or (b) a second nucleotide
sequence comprising the complement of the first nucleotide
sequence.
[0052] Preferably, the first nucleotide sequence comprises a
nucleic acid sequence selected from the group consisting of SEQ ID
NOs: 1, 3,5, 7, 9, 11, 13, and 15.
[0053] Nucleic acid fragments encoding at least a portion of
several NPR1 polypeptides have been isolated and identified by
comparison of random plant cDNA sequences to public databases
containing nucleotide and protein sequences using the BLAST
algorithms well known to those skilled in the art. The nucleic acid
fragments of the instant invention may be used to isolate cDNAs and
genes encoding homologous proteins from the same or other plant
species. Isolation of homologous genes using sequence-dependent
protocols is well known in the art. Examples of sequence-dependent
protocols include, but are not limited to, methods of nucleic acid
hybridization, and methods of DNA and RNA amplification as
exemplified by various uses of nucleic acid amplification
technologies (e.g., polymerase chain reaction, ligase chain
reaction).
[0054] For example, genes encoding other NPR1 s, either as cDNAs or
genomic DNAs, could be isolated directly by using all or a portion
of the instant nucleic acid fragments as DNA hybridization probes
to screen libraries from any desired plant employing methodology
well known to those skilled in the art. Specific oligonucleotide
probes based upon the instant nucleic acid sequences can be
designed and synthesized by methods known in the art (Maniatis).
Moreover, an entire sequence can be used directly to synthesize DNA
probes by methods known to the skilled artisan such as random
primer DNA labeling, nick translation, end-labeling techniques, or
RNA probes using available in vitro transcription systems. In
addition, specific primers can be designed and used to amplify a
part or all of the instant sequences. The resulting amplification
products can be labeled directly during amplification reactions or
labeled after amplification reactions, and used as probes to
isolate full length cDNA or genomic fragments under conditions of
appropriate stringency.
[0055] In addition, two short segments of the instant nucleic acid
fragments may be used in polymerase chain reaction protocols to
amplify longer nucleic acid fragments encoding homologous genes
from DNA or RNA. The polymerase chain reaction may also be
performed on a library of cloned nucleic acid fragments wherein the
sequence of one primer is derived from the instant nucleic acid
fragments, and the sequence of the other primer takes advantage of
the presence of the polyadenylic acid tracts to the 3' end of the
mRNA precursor encoding plant genes. Alternatively, the second
primer sequence may be based upon sequences derived from the
cloning vector. For example, the skilled artisan can follow the
RACE protocol (Frohman et al. (1988) Proc. Natl. Acad. Sci. USA
85:8998-9002) to generate cDNAs by using PCR to amplify copies of
the region between a single point in the transcript and the 3' or
5' end. Primers oriented in the 3' and 5' directions can be
designed from the instant sequences. Using commercially available
3' RACE or 5' RACE systems (BRL), specific 3' or 5' cDNA fragments
can be isolated (Ohara et al. (1989) Proc. Natl. Acad. Sci. USA
86:5673-5677; Loh et al. (1989) Science 243:217-220). Products
generated by the 3' and 5' RACE procedures can be combined to
generate full-length cDNAs (Frohman and Martin (1989) Techniques
1:165). Consequently, a polynucleotide comprising a nucleotide
sequence of at least 60 (preferably at least 40, most preferably at
least 30) contiguous nucleotides derived from a nucleotide sequence
selected from the group consisting of SEQ ID NOs: 1, 3, 5, 7, 9,
11, 13, and 15, and the complement of such nucleotide sequences may
be used in such methods to obtain a nucleic acid fragment encoding
a substantial portion of an amino acid sequence of a
polypeptide.
[0056] The present invention relates to a method of obtaining a
nucleic acid fragment encoding a substantial portion of an NPR1
polypeptide, preferably a substantial portion of a plant NPR1
polypeptide, comprising the steps of: synthesizing an
oligonucleotide primer comprising a nucleotide sequence of at least
60 (preferably at least 40, most preferably at least 30) contiguous
nucleotides derived from a nucleotide sequence selected from the
group consisting of SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, and 15, and
the complement of such nucleotide sequences; and amplifying a
nucleic acid fragment (preferably a cDNA inserted in a cloning
vector) using the oligonucleotide primer. The amplified nucleic
acid fragment preferably will encode a portion of an NPR1
polypeptide.
[0057] Availability of the instant nucleotide and deduced amino
acid sequences facilitates immunological screening of cDNA
expression libraries. Synthetic peptides representing portions of
the instant amino acid sequences may be synthesized. These peptides
can be used to immunize animals to produce polyclonal or monoclonal
antibodies with specificity for peptides or proteins comprising the
amino acid sequences. These antibodies can be then be used to
screen cDNA expression libraries to isolate full-length cDNA clones
of interest (Lerner (1984) Adv. Immunol. 36:1-34; Maniatis).
[0058] The polynucleotides of the present invention may be used to
assemble chimeric genes which may be introduced into viruses or
host cells. In another embodiment, this invention concerns viruses
and host cells comprising either the chimeric genes of the
invention as described herein or an isolated polynucleotide of the
invention as described herein. Examples of host cells which can be
used to practice the invention include, but are not limited to,
yeast, bacteria, and plants.
[0059] The nucleic acid fragments of the instant invention may be
used to create transgenic plants in which the disclosed
polypeptides are present at higher levels than normal or in cell
types or developmental stages in which they are not normally found.
This would have the effect of altering the level of pathogen
resistance in those cells. The NPR1 gene in Arabidopsis thaliana is
involved in acquired pathogen resistance, thus overexpression of
the polynucleotides of the present invention should allow the
control of crop pathogens.
[0060] Overexpression of the proteins of the instant invention may
be accomplished by first constructing a chimeric gene in which the
coding region is operably linked to a promoter capable of directing
expression of a gene in the desired tissues at the desired stage of
development. The chimeric gene may comprise promoter sequences and
translation leader sequences derived from the same genes. 3'
Non-coding sequences encoding transcription termination signals may
also be provided. The instant chimeric gene may also comprise one
or more introns in order to facilitate gene expression.
[0061] Plasmid vectors comprising the instant isolated
polynucleotide (or chimeric gene) may be constructed. The choice of
plasmid vector is dependent upon the method that will be used to
transform host cells. The skilled artisan is well aware of the
genetic elements that must be present on the plasmid vector in
order to successfully transform, select and propagate host cells
containing the isolated polynucleotide or chimeric gene. The
skilled artisan will also recognize that different independent
transformation events will result in different levels and patterns
of expression (Jones et al. (1985) EMBO J. 4:2411-2418; De Almeida
et al. (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple
events must be screened in order to obtain lines displaying the
desired expression level and pattern. Such screening may be
accomplished by Southern analysis of DNA, Northern analysis of mRNA
expression, Western analysis of protein expression, or phenotypic
analysis.
[0062] For some applications it may be useful to direct the instant
polypeptide to different cellular compartments, or to facilitate
its secretion from the cell. It is thus envisioned that the
chimeric gene described above may be further supplemented by
directing the coding sequence to encode the instant polypeptide
with appropriate intracellular targeting sequences such as transit
sequences (Keegstra (1989) Cell 56:247-253), signal sequences or
sequences encoding endoplasmic reticulum localization (Chrispeels
(1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear
localization signals (Raikhel (1992) Plant Phys. 100:1627-1632)
with or without removing targeting sequences that are already
present. While the references cited give examples of each of these,
the list is not exhaustive and more targeting signals of use may be
discovered in the future.
[0063] In another embodiment, the present invention concerns a
polypeptide of at least XXX amino acids that has at least XX%
identity based on the Clustal method of alignment when compared to
a polypeptide selected from the group consisting of SEQ ID NOs: 2,
4, 6, 8, 10, 12, 14, and 16.
[0064] The instant polypeptides (or portions thereof) may be
produced in heterologous host cells, particularly in the cells of
microbial hosts, and can be used to prepare antibodies to these
proteins by methods well known to those skilled in the art. The
antibodies are useful for detecting the polypeptides of the instant
invention in situ in cells or in vitro in cell extracts. Preferred
heterologous host cells for production of the instant polypeptides
are microbial hosts. Microbial expression systems and expression
vectors containing regulatory sequences that direct high level
expression of foreign proteins are well known to those skilled in
the art. Any of these could be used to construct a chimeric gene
for production of the instant polypeptides. This chimeric gene
could then be introduced into appropriate microorganisms via
transformation to provide high level expression of the encoded
NPR1. An example of a vector for high level expression of the
instant polypeptides in a bacterial host is provided (Example
6).
[0065] All or a substantial portion of the polynucleotides of the
instant invention may also be used as probes for genetically and
physically mapping the genes that they are a part of, and used as
markers for traits linked to those genes. Such information may be
useful in plant breeding in order to develop lines with desired
phenotypes. For example, the instant nucleic acid fragments may be
used as restriction fragment length polymorphism (RFLP) markers.
Southern blots (Maniatis) of restriction-digested plant genomic DNA
may be probed with the nucleic acid fragments of the instant
invention. The resulting banding patterns may then be subjected to
genetic analyses using computer programs such as MapMaker (Lander
et al. (1987) Genomics 1:174-181) in order to construct a genetic
map. In addition, the nucleic acid fragments of the instant
invention may be used to probe Southern blots containing
restriction endonuclease-treated genomic DNAs of a set of
individuals representing parent and progeny of a defined genetic
cross. Segregation of the DNA polymorphisms is noted and used to
calculate the position of the instant nucleic acid sequence in the
genetic map previously obtained using this population (Botstein et
al. (1980) Am. J. Hum. Genet. 32:314-331).
[0066] The production and use of plant gene-derived probes for use
in genetic mapping is described in Bernatzky and Tanksley (1986)
Plant Mol. Biol. Reporter 4:37-41. Numerous publications describe
genetic mapping of specific cDNA clones using the methodology
outlined above or variations thereof. For example, F2 intercross
populations, backcross populations, randomly mated populations,
near isogenic lines, and other sets of individuals may be used for
mapping. Such methodologies are well known to those skilled in the
art.
[0067] Nucleic acid probes derived from the instant nucleic acid
sequences may also be used for physical mapping (i.e., placement of
sequences on physical maps; see Hoheisel et al. In: Nonmammalian
Genomic Analysis: A Practical Guide, Academic press 1996, pp.
319-346, and references cited therein).
[0068] In another embodiment, nucleic acid probes derived from the
instant nucleic acid sequences may be used in direct fluorescence
in situ hybridization (FISH) mapping (Trask (1991) Trends Genet.
7:149-154). Although current methods of FISH mapping favor use of
large clones (several to several hundred KB; see Laan et al. (1995)
Genome Res. 5:13-20), improvements in sensitivity may allow
performance of FISH mapping using shorter probes.
[0069] A variety of nucleic acid amplification-based methods of
genetic and physical mapping may be carried out using the instant
nucleic acid sequences. Examples include allele-specific
amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96),
polymorphism of PCR-amplified fragments (CAPS; Sheffield et al.
(1993) Genomics 16:325-332), allele-specific ligation (Landegren et
al. (1988) Science 241:1077-1080), nucleotide extension reactions
(Sokolov (1990) Nucleic Acid Res. 18:367 1), Radiation Hybrid
Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy
Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For
these methods, the sequence of a nucleic acid fragment is used to
design and produce primer pairs for use in the amplification
reaction or in primer extension reactions. The design of such
primers is well known to those skilled in the art. In methods
employing PCR-based genetic mapping, it may be necessary to
identify DNA sequence differences between the parents of the
mapping cross in the region corresponding to the instant nucleic
acid sequence. This, however, is generally not necessary for
mapping methods.
EXAMPLES
[0070] The present invention is further defined in the following
Examples, in which parts and percentages are by weight and degrees
are Celsius, unless otherwise stated. It should be understood that
these Examples, while indicating preferred embodiments of the
invention, are given by way of illustration only. From the above
discussion and these Examples, one skilled in the art can ascertain
the essential characteristics of this invention, and without
departing from the spirit and scope thereof, can make various
changes and modifications of the invention to adapt it to various
usages and conditions. Thus, various modifications of the invention
in addition to those shown and described herein will be apparent to
those skilled in the art from the foregoing description. Such
modifications are also intended to fall within the scope of the
appended claims.
[0071] The disclosure of each reference set forth herein is
incorporated herein by reference in its entirety.
Example 1
[0072] Composition of cDNA Libraries; Isolation and Sequencing of
cDNA Clones
[0073] cDNA libraries representing mRNAs from various corn, rice,
and wheat tissues were prepared. The characteristics of the
libraries are described below.
2TABLE 2 cDNA Libraries from Corn, Rice, and Wheat Library Tissue
Clone cdt1c Corn Developing Tassel cdt1c.pk001.16 p0006 Corn Young
Shoot p0006.cbyvc82rx rl0n Rice 15 Day Old Leaf* r10n.pk0063.d10
rr1 Rice Root of Two Week Old rr1.pk0001.a11 Developing Seedling
wre1n Wheat Root From 7 Day Old wreln.pk0122.c2 Etiolated Seedling*
*These libraries were normalized essentially as described in U.S.
Pat. No. 5,482,845, incorporated herein by reference.
[0074] cDNA libraries may be prepared by any one of many methods
available. For example, the cDNAs may be introduced into plasmid
vectors by first preparing the cDNA libraries in Uni-ZAP.TM. XR
vectors according to the manufacturer's protocol (Stratagene
Cloning Systems, La Jolla, Calif.). The Uni-ZAP.TM. XR libraries
are converted into plasmid libraries according to the protocol
provided by Stratagene. Upon conversion, cDNA inserts will be
contained in the plasmid vector pBluescript. In addition, the cDNAs
may be introduced directly into precut Bluescript II SK(+) vectors
(Stratagene) using T4 DNA ligase (New England Biolabs), followed by
transfection into DH10B cells according to the manufacturer's
protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid
vectors, plasmid DNAs are prepared from randomly picked bacterial
colonies containing recombinant pBluescript plasmids, or the insert
cDNA sequences are amplified via polymerase chain reaction using
primers specific for vector sequences flanking the inserted cDNA
sequences. Amplified insert DNAs or plasmid DNAs are sequenced in
dye-primer sequencing reactions to generate partial cDNA sequences
(expressed sequence tags or "ESTs"; see Adams et al., (1991)
Science 252:1651-1656). The resulting ESTs are analyzed using a
Perkin Elmer Model 377 fluorescent sequencer.
[0075] Full-insert sequence (FIS) data is generated utilizing a
modified transposition protocol. Clones identified for FIS are
recovered from archived glycerol stocks as single colonies, and
plasmid DNAs are isolated via alkaline lysis. Isolated DNA
templates are reacted with vector primed M13 forward and reverse
oligonucleotides in a PCR-based sequencing reaction and loaded onto
automated sequencers. Confirmation of clone identification is
performed by sequence alignment to the original EST sequence from
which the FIS request is made.
[0076] Confirmed templates are transposed via the Primer Island
transposition kit (PE Applied Biosystems, Foster City, Calif.)
which is based upon the Saccharomyces cerevisiae Ty1 transposable
element (Devine and Boeke (1994) Nucleic Acids Res. 22:3765-3772).
The in vitro transposition system places unique binding sites
randomly throughout a population of large DNA molecules. The
transposed DNA is then used to transform DH10B electro-competent
cells (Gibco BRL/Life Technologies, Rockville, Md.) via
electroporation. The transposable element contains an additional
selectable marker (named DHFR; Fling and Richards (1983) Nucleic
Acids Res. 11:5147-5158), allowing for dual selection on agar
plates of only those subclones containing the integrated
transposon. Multiple subclones are randomly selected from each
transposition reaction, plasmid DNAs are prepared via alkaline
lysis, and templates are sequenced (ABI Prism dye-terminator
ReadyReaction mix) outward from the transposition event site,
utilizing unique primers specific to the binding sites within the
transposon.
[0077] Sequence data is collected (ABI Prism Collections) and
assembled using Phred/Phrap (P. Green, University of Washington,
Seattle). Phrep/Phrap is a public domain software program which
re-reads the ABI sequence data, re-calls the bases, assigns quality
values, and writes the base calls and quality values into editable
output files. The Phrap sequence assembly program uses these
quality values to increase the accuracy of the assembled sequence
contigs. Assemblies are viewed by the Consed sequence editor (D.
Gordon, University of Washington, Seattle).
[0078] In some of the clones the cDNA fragment corresponds to a
portion of the 3'-terminus of the gene and does not cover the
entire open reading frame. In order to obtain the upstream
information one of two different protocols are used. The first of
these methods results in the production of a fragment of DNA
containing a portion of the desired gene sequence while the second
method results in the production of a fragment containing the
entire open reading frame. Both of these methods use two rounds of
PCR amplification to obtain fragments from one or more libraries.
The libraries some times are chosen based on previous knowledge
that the specific gene should be found in a certain tissue and some
times are randomly-chosen. Reactions to obtain the same gene may be
performed on several libraries in parallel or on a pool of
libraries. Library pools are normally prepared using from 3 to 5
different libraries and normalized to a uniform dilution. In the
first round of amplification both methods use a vector-specific
(forward) primer corresponding to a portion of the vector located
at the 5'-terminus of the clone coupled with a gene-specific
(reverse) primer. The first method uses a sequence that is
complementary to a portion of the already known gene sequence while
the second method uses a gene-specific primer complementary to a
portion of the 3'-untranslated region (also referred to as UTR). In
the second round of amplification a nested set of primers is used
for both methods. The resulting DNA fragment is ligated into a
pBluescript vector using a commercial kit and following the
manufacturer's protocol. This kit is selected from many available
from several vendors including Invitrogen (Carlsbad, Calif.),
Promega Biotech (Madison, Wis.), and Gibco-BRL (Gaithersburg, Md.).
The plasmid DNA is isolated by alkaline lysis method and submitted
for sequencing and assembly using Phred/Phrap, as above.
Example 2
[0079] Identification of cDNA Clones
[0080] cDNA clones encoding NPR1 were identified by conducting
BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J.
Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/)
searches for similarity to sequences contained in the BLAST "nr"
database (comprising all non-redundant GenBank CDS translations,
sequences derived from the 3-dimensional structure Brookhaven
Protein Data Bank, the last major release of the SWISS-PROT protein
sequence database, EMBL, and DDBJ databases). The cDNA sequences
obtained in Example 1 were analyzed for similarity to all publicly
available DNA sequences contained in the "nr" database using the
BLASTN algorithm provided by the National Center for Biotechnology
Information (NCBI). The DNA sequences were translated in all
reading frames and compared for similarity to all publicly
available protein sequences contained in the "nr" database using
the BLASTX algorithm (Gish and States (1993) Nat. Genet. 3:266-272)
provided by the NCBI. For convenience, the P-value (probability) of
observing a match of a cDNA sequence to a sequence contained in the
searched databases merely by chance as calculated by BLAST are
reported herein as "pLog" values, which represent the negative of
the logarithm of the reported P-value. Accordingly, the greater the
pLog value, the greater the likelihood that the cDNA sequence and
the BLAST "hit" represent homologous proteins.
[0081] ESTs submitted for analysis are compared to the genbank
database as described above. ESTs that contain sequences more 5- or
3-prime can be found by using the BLASTn algorithm (Altschul et al
(1997) Nucleic Acids Res. 25:3389-3402.) against the DuPont
proprietary database comparing nucleotide sequences that share
common or overlapping regions of sequence homology. Where common or
overlapping sequences exist between two or more nucleic acid
fragments, the sequences can be assembled into a single contiguous
nucleotide sequence, thus extending the original fragment in either
the 5 or 3 prime direction. Once the most 5-prime EST is
identified, its complete sequence can be determined by Full Insert
Sequencing as described in Example 1. Homologous genes belonging to
different species can be found by comparing the amino acid sequence
of a known gene (from either a proprietary source or a public
database) against an EST database using the tBLASTn algorithm. The
tBLASTn algorithm searches an amino acid query against a nucleotide
database that is translated in all 6 reading frames. This search
allows for differences in nucleotide codon usage between different
species, and for codon degeneracy.
Example 3
[0082] Characterization of cDNA Clones Encoding NPR1
[0083] The BLASTX search using the EST sequences from clones
cdt1c.pk001.16, rr1.pk0001.a11 and wre1n.pk0122.c2 revealed
similarity of the proteins encoded by the cDNAs to NPR1 from
Arabidopsis thaliana (NCBI General Identifier No. 1773295). The
BLAST results for each of these ESTs are shown in Table 3:
3TABLE 3 BLAST Results for Clones Encoding Polypeptides Homologous
to NPR1 BLAST pLog Score NCBI GI No. Clone Status SEQ ID NO:
1773295 cdt1c.pk001.16 EST 2 13.22 rr1.pk0001.a11 EST 4 32.30
wre1n.pk0122.c2 EST 6 15.00
[0084] The sequence of the entire cDNA insert in clones
cdt1c.pk001.16, rr1.pk0001.a11, and wre1n.pk0122.c2 was obtained.
Additional searching of the DuPont proprietary database allowed the
identification of another corn and another rice clones encoding
NPR1 and the sequence of the entire cDNA insert in these clones was
also obtained. The BLAST search using the sequences from clones
listed in Table 4 revealed similarity of the hypothetical proteins
encoded by Arabidopsis thaliana contigs and by the cDNAs to NPR1
from Arabidopsis thaliana (NCBI General Identifier No. 1773295).
Shown in Table 4 are the BLAST results for the sequences of the
entire cDNA inserts comprising the indicated cDNA clones ("FIS"),
or for sequences encoding an entire protein ("CGS"):
4TABLE 4 BLAST Results for Sequences Encoding Polypeptides
Homologous to NPR1 BLAST pLog Score Clone Status SEQ ID NO: 1773295
p0006.cbyvc82rx FIS 8 60.22 r10n.pk0063.d10:fis CGS 10 138.00
rr1.pk0001.a11:fis FIS 12 91.22 wre1n.pk0122.c2:fis FIS 14
22.52
[0085] The sequence of the entire cDNA insert in clone
rr1.pk0001.a11 corresponds to a portion of the 3'-terminus of the
gene and does not cover the entire open reading frame.
Amplification was used to obtain nucleic acid sequence encoding the
entire open reading frame of this clone. The BLASTP search using
the amino acid sequences derived from the clone listed in Table 5
revealed similarity of the polypeptides encoded Arabidopsis
thaliana contigs encoding hypothetical proteins and by the cDNAs to
NPR1 from Arabidopsis thaliana (NCBI General Identifier No.
1773295). Shown in Table 5 are the BLAST results for the sequences
encoding the entire open reading frame ("CGS"):
5TABLE 5 BLAST Results for Sequences Encoding Polypeptides
Homologous to NPR1 BLAST pLog Score Clone Status SEQ ID NO: 1773295
rr1.pk0001.a11:cgs CGS 16 100.00
[0086] FIG. 1 presents an alignment of the amino acid sequences set
forth in SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16 and the
Arabidopsis thaliana NPR1 sequence (NCBI General Identifier No.
1773295). The data in Table 6 represents a calculation of the
percent identity of the amino acid sequences set forth in SEQ ID
NOs: 2, 4, 6, 8, 10, 12, 14, and 16 and the Arabidopsis thaliana
NPR1 sequence (SEQ ID NO: 17).
6TABLE 6 Percent Identity of Amino Acid Sequences Deduced From the
Nucleotide Sequences of cDNA Clones Encoding Polypeptides
Homologous to NPR1 Percent Identity to Clone SEQ ID NO: 1773295
cdt1c.pk001.16 2 45.8 rr1.pk0001.a11 4 47.6 wre1n.pk0122.c2 6 40.0
p0006.cbyvc82rx 8 40.3 r10n.pk0063.d10:fis 10 42.1
rr1.pk0001.a11:fis 12 39.1 wre1n.pk0122.c2:fis 14 33.7
rr1.pk0001.a11:cgs 16 34.1
[0087] Sequence alignments and percent identity calculations were
performed using the Megalign program of the LASERGENE
bioinformatics computing suite (DNASTAR Inc., Madison, Wis.).
Multiple alignment of the sequences was performed using the Clustal
method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153)
with the default parameters (GAP PENALTY=10, GAP LENGTH
PENALTY=10). Default parameters for pairwise alignments using the
Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS
SAVED=5. Sequence alignments and BLAST scores and probabilities
indicate that the nucleic acid fragments comprising the instant
cDNA clones encode two entire rice NPR1 isozymes and substantial
portions of the same. The instant nucleic acid fragments also
encode substantial portions of one wheat NPR1 and two wheat NPR1
isozymes. These sequences represent the first corn, rice, and wheat
sequences encoding NPR1 known to Applicant.
Example 4
[0088] Expression of Chimeric Genes in Monocot Cells
[0089] A chimeric gene comprising a cDNA encoding the instant
polypeptides in sense orientation with respect to the maize 27 kD
zein promoter that is located 5' to the cDNA fragment, and the 10
kD zein 3' end that is located 3' to the cDNA fragment, can be
constructed. The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites (NcoI or SmaI) can be
incorporated into the oligonucleotides to provide proper
orientation of the DNA fragment when inserted into the digested
vector pML 103 as described below. Amplification is then performed
in a standard PCR. The amplified DNA is then digested with
restriction enzymes NcoI and SmaI and fractionated on an agarose
gel. The appropriate band can be isolated from the gel and combined
with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid
pML103 has been deposited under the terms of the Budapest Treaty at
ATCC (American Type Culture Collection, 10801 University Blvd.,
Manassas, Va. 20110-2209), and bears accession number ATCC 97366.
The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter
fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI
fragment from the 3' end of the maize 10 kD zein gene in the vector
pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at
15.degree. C. overnight, essentially as described (Maniatis). The
ligated DNA may then be used to transform E. coli XL1-Blue
(Epicurian Coli XL-1 Blue.TM.; Stratagene). Bacterial transformants
can be screened by restriction enzyme digestion of plasmid DNA and
limited nucleotide sequence analysis using the dideoxy chain
termination method (Sequenase.TM. DNA Sequencing Kit; U.S.
Biochemical). The resulting plasmid construct would comprise a
chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD
zein promoter, a cDNA fragment encoding the instant polypeptides,
and the 10 kD zein 3' region.
[0090] The chimeric gene described above can then be introduced
into corn cells by the following procedure. Immature corn embryos
can be dissected from developing caryopses derived from crosses of
the inbred corn lines H99 and LH132. The embryos are isolated 10 to
11 days after pollination when they are 1.0 to 1.5 mm long. The
embryos are then placed with the axis-side facing down and in
contact with agarose-solidified N6 medium (Chu et al. (1975) Sci.
Sin. Peking 18:659-668). The embryos are kept in the dark at
27.degree. C. Friable embryogenic callus consisting of
undifferentiated masses of cells with somatic proembryoids and
embryoids borne on suspensor structures proliferates from the
scutellum of these immature embryos. The embryogenic callus
isolated from the primary explant can be cultured on N6 medium and
sub-cultured on this medium every 2 to 3 weeks.
[0091] The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst
Ag, Frankfurt, Germany) may be used in transformation experiments
in order to provide for a selectable marker. This plasmid contains
the Pat gene (see European Pat. Publication 0 242 236) which
encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT
confers resistance to herbicidal glutamine synthetase inhibitors
such as phosphinothricin. The pat gene in p35S/Ac is under the
control of the 35S promoter from Cauliflower Mosaic Virus (Odell et
al. (1985) Nature 313:810-812) and the 3' region of the nopaline
synthase gene from the T-DNA of the Ti plasmid of Agrobacterium
tumefaciens.
[0092] The particle bombardment method (Klein et al. (1987) Nature
327:70-73) may be used to transfer genes to the callus culture
cells. According to this method, gold particles (1 .mu.m in
diameter) are coated with DNA using the following technique. Ten
.mu.g of plasmid DNAs are added to 50 .mu.L of a suspension of gold
particles (60 mg per mL). Calcium chloride (50 .mu.L of a 2.5 M
solution) and spermidine free base (20 .mu.L of a 1.0 M solution)
are added to the particles. The suspension is vortexed during the
addition of these solutions. After 10 minutes, the tubes are
briefly centrifuged (5 sec at 15,000 rpm) and the supernatant
removed. The particles are resuspended in 200 .mu.L of absolute
ethanol, centrifuged again and the supernatant removed. The ethanol
rinse is performed again and the particles resuspended in a final
volume of 30 .mu.L of ethanol. An aliquot (5 .mu.L) of the
DNA-coated gold particles can be placed in the center of a
Kapton.TM. flying disc (Bio-Rad Labs). The particles are then
accelerated into the corn tissue with a Biolistic.TM. PDS-1000/He
(Bio-Rad Instruments, Hercules Calif.), using a helium pressure of
1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0
cm.
[0093] For bombardment, the embryogenic tissue is placed on filter
paper over agarose-solidified N6 medium. The tissue is arranged as
a thin lawn and covered a circular area of about 5 cm in diameter.
The petri dish containing the tissue can be placed in the chamber
of the PDS-1000/He approximately 8 cm from the stopping screen. The
air in the chamber is then evacuated to a vacuum of 28 inches of
Hg. The macrocarrier is accelerated with a helium shock wave using
a rupture membrane that bursts when the He pressure in the shock
tube reaches 1000 psi.
[0094] Seven days after bombardment the tissue can be transferred
to N6 medium that contains bialophos (5 mg per liter) and lacks
casein or proline. The tissue continues to grow slowly on this
medium. After an additional 2 weeks the tissue can be transferred
to fresh N6 medium containing bialophos. After 6 weeks, areas of
about 1 cm in diameter of actively growing callus can be identified
on some of the plates containing the bialophos-supplemented medium.
These calli may continue to grow when sub-cultured on the selective
medium.
[0095] Plants can be regenerated from the transgenic callus by
first transferring clusters of tissue to N6 medium supplemented
with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be
transferred to regeneration medium (Fromm et al. (1 990)
Bio/Technology 8:833-839).
Example 5
[0096] Expression of Chimeric Genes in Dicot Cells
[0097] A seed-specific expression cassette composed of the promoter
and transcription terminator from the gene encoding the .beta.
subunit of the seed storage protein phaseolin from the bean
Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem.
261:9228-9238) can be used for expression of the instant
polypeptides in transformed soybean. The phaseolin cassette
includes about 500 nucleotides upstream (5') from the translation
initiation codon and about 1650 nucleotides downstream (3') from
the translation stop codon of phaseolin. Between the 5' and 3'
regions are the unique restriction endonuclease sites Nco I (which
includes the ATG translation initiation codon), Sma I, Kpn I and
Xba I. The entire cassette is flanked by Hind III sites.
[0098] The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites can be incorporated into the
oligonucleotides to provide proper orientation of the DNA fragment
when inserted into the expression vector. Amplification is then
performed as described above, and the isolated fragment is inserted
into a pUC18 vector carrying the seed expression cassette.
[0099] Soybean embryos may then be transformed with the expression
vector comprising sequences encoding the instant polypeptides. To
induce somatic embryos, cotyledons, 3-5 mm in length dissected from
surface sterilized, immature seeds of the soybean cultivar A2872,
can be cultured in the light or dark at 26.degree. C. on an
appropriate agar medium for 6-10 weeks. Somatic embryos which
produce secondary embryos are then excised and placed into a
suitable liquid medium. After repeated selection for clusters of
somatic embryos which multiplied as early, globular staged embryos,
the suspensions are maintained as described below.
[0100] Soybean embryogenic suspension cultures can be maintained in
35 mL liquid media on a rotary shaker, 150 rpm, at 26.degree. C.
with florescent lights on a 16:8 hour day/night schedule. Cultures
are subcultured every two weeks by inoculating approximately 35 mg
of tissue into 35 mL of liquid medium.
[0101] Soybean embryogenic suspension cultures may then be
transformed by the method of particle gun bombardment (Klein et al.
(1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A
DuPont Biolistic.TM. PDS1000/HE instrument (helium retrofit) can be
used for these transformations.
[0102] A selectable marker gene which can be used to facilitate
soybean transformation is a chimeric gene composed of the 35S
promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature
313:810-812), the hygromycin phosphotransferase gene from plasmid
pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the
3' region of the nopaline synthase gene from the T-DNA of the Ti
plasmid of Agrobacterium tumefaciens. The seed expression cassette
comprising the phaseolin 5' region, the fragment encoding the
instant polypeptides and the phaseolin 3' region can be isolated as
a restriction fragment. This fragment can then be inserted into a
unique restriction site of the vector carrying the marker gene.
[0103] To 50 .mu.L of a 60 mg/mL 1 .mu.m gold particle suspension
is added (in order): 5 .mu.L DNA (1 .mu.g/.mu.L), 20 .mu.L
spermidine (0.1 M), and 50 .mu.L CaCl.sub.2 (2.5 M). The particle
preparation is then agitated for three minutes, spun in a microfuge
for 10 seconds and the supernatant removed. The DNA-coated
particles are then washed once in 400 .mu.L 70% ethanol and
resuspended in 40 .mu.L of anhydrous ethanol. The DNA/particle
suspension can be sonicated three times for one second each. Five
.mu.L of the DNA-coated gold particles are then loaded on each
macro carrier disk.
[0104] Approximately 300-400 mg of a two-week-old suspension
culture is placed in an empty 60.times.15 mm petri dish and the
residual liquid removed from the tissue with a pipette. For each
transformation experiment, approximately 5-10 plates of tissue are
normally bombarded. Membrane rupture pressure is set at 1100 psi
and the chamber is evacuated to a vacuum of 28 inches mercury. The
tissue is placed approximately 3.5 inches away from the retaining
screen and bombarded three times. Following bombardment, the tissue
can be divided in half and placed back into liquid and cultured as
described above.
[0105] Five to seven days post bombardment, the liquid media may be
exchanged with fresh media, and eleven to twelve days post
bombardment with fresh media containing 50 mg/mL hygromycin. This
selective media can be refreshed weekly. Seven to eight weeks post
bombardment, green, transformed tissue may be observed growing from
untransformed, necrotic embryogenic clusters. Isolated green tissue
is removed and inoculated into individual flasks to generate new,
clonally propagated, transformed embryogenic suspension cultures.
Each new line may be treated as an independent transformation
event. These suspensions can then be subcultured and maintained as
clusters of immature embryos or regenerated into whole plants by
maturation and germination of individual somatic embryos.
Example 6
[0106] Expression of Chimeric Genes in Microbial Cells
[0107] The cDNAs encoding the instant polypeptides can be inserted
into the T7 E. coli expression vector pBT430. This vector is a
derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135)
which employs the bacteriophage T7 RNA polymerase/T7 promoter
system. Plasmid pBT430 was constructed by first destroying the EcoR
I and Hind III sites in pET-3a at their original positions. An
oligonucleotide adaptor containing EcoR I and Hind III sites was
inserted at the BamH I site of pET-3a. This created pET-3aM with
additional unique cloning sites for insertion of genes into the
expression vector. Then, the Nde I site at the position of
translation initiation was converted to an Nco I site using
oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM
in this region, 5'-CATATGG, was converted to 5'-CCCATGG in
pBT430.
[0108] Plasmid DNA containing a cDNA may be appropriately digested
to release a nucleic acid fragment encoding the protein. This
fragment may then be purified on a 1% low melting agarose gel.
Buffer and agarose contain 10 .mu.g/ml ethidium bromide for
visualization of the DNA fragment. The fragment can then be
purified from the agarose gel by digestion with GELase.TM.
(Epicentre Technologies, Madison, Wis.) according to the
manufacturer's instructions, ethanol precipitated, dried and
resuspended in 20 .mu.L of water. Appropriate oligonucleotide
adapters may be ligated to the fragment using T4 DNA ligase (New
England Biolabs (NEB), Beverly, Mass.). The fragment containing the
ligated adapters can be purified from the excess adapters using low
melting agarose as described above. The vector pBT430 is digested,
dephosphorylated with alkaline phosphatase (NEB) and deproteinized
with phenol/chloroform as described above. The prepared vector
pBT430 and fragment can then be ligated at 16.degree. C. for 15
hours followed by transformation into DH5 electrocompetent cells
(GIBCO BRL). Transformants can be selected on agar plates
containing LB media and 100 .mu.g/mL ampicillin. Transformants
containing the gene encoding the instant polypeptides are then
screened for the correct orientation with respect to the T7
promoter by restriction enzyme analysis.
[0109] For high level expression, a plasmid clone with the cDNA
insert in the correct orientation relative to the T7 promoter can
be transformed into E. coli strain BL2 1 (DE3) (Studier et al.
(1986) J. Mol. Biol. 189:113-130). Cultures are grown in LB medium
containing ampicillin (100 mg/L) at 25.degree. C. At an optical
density at 600 nm of approximately 1, IPTG
(isopropylthio-.beta.-galactoside, the inducer) can be added to a
final concentration of 0.4 mM and incubation can be continued for 3
h at 25.degree.. Cells are then harvested by centrifugation and
re-suspended in 50 .mu.L of 50 mM Tris-HCl at pH 8.0 containing 0.1
mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of
1 mm glass beads can be added and the mixture sonicated 3 times for
about 5 seconds each time with a microprobe sonicator. The mixture
is centrifuged and the protein concentration of the supernatant
determined. One .mu.g of protein from the soluble fraction of the
culture can be separated by SDS-polyacrylamide gel electrophoresis.
Gels can be observed for protein bands migrating at the expected
molecular weight.
Sequence CWU 0
0
* * * * *
References